Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial

Rationale Idiopathic pulmonary fibrosis (IPF) has a dismal prognosis. Mesenchymal stromal cells (MSCs) have shown benefit in other inflammatory diseases. Objectives To evaluate the safety and feasibility of endobronchial administration of bone marrow autologous MSCs (BM-MSC) in patients with mild-to...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Arantza Campo, José María González-Ruiz, Enrique Andreu, Ana B. Alcaide, María M. Ocón, Juan De-Torres, Jesús Pueyo, Rosa Cordovilla, Eva Villaron, Fermín Sanchez-Guijo, Miguel Barrueco, Jorge Nuñez-Córdoba, Felipe Prósper, Javier J. Zulueta
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	European Respiratory Society 2021-06-01
Schriftenreihe:	ERJ Open Research
Online-Zugang:	http://openres.ersjournals.com/content/7/2/00773-2020.full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!